This role will help to build upon the strong technology and execution found at BTO. This is considered an onsite role at our Union City lab, with flexibility to work from home or at our Menlo Park site when applicable.
Responsibilities
Meet with CLIA lab staff and LIMS Engineers to coordinate updates to existing products, or launch of new workflows
Support lab operators in resolving LIMS issues to minimize sample turnaround time
Triage & escalate unresolved technical issues to appropriate team members
Monitor sample queues and follow up on unresolved issues or delays
Observe and collect feedback in the lab of LIMS usage and identify improvement opportunities
Assist in testing and documenting new LIMS workflow versions
Ensure compliance to all relevant corporate and regulatory requirements
Requirements
Bachelor's degree with Biological or Computational focus
Hands-on laboratory bench experience, including undergraduate research projects or internships.
Experience configuring or developing LIMS, productivity apps, or other lab tools/automations
Ability to troubleshoot and diagnose advanced technical issues
Strong attention to detail and ability to work flexibly and well under given timeframes
Highly organized, strong written and verbal communication skills
Enjoy a wide variety of daily tasks in a fast-paced, time-sensitive environment
Nice-To-Haves
Experience working in CLIA Lab, medical device, or pharma
Experience with data analysis using Python, SQL, or Excel
Familiarity with Quality Management Systems and related regulations (CFR 21 Part 11, ISO 13485, etc)
Benefits And Perks
Working alongside brilliant, kind, passionate and dedicated colleagues, in an empowering environment, toward a global vision, striving for a future in which transformative molecular diagnostics can help millions of patients
Open, transparent culture that includes weekly Town Hall meetings
The ability to indirectly or directly change the lives of hundreds of thousand patients
Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered up to 80%
Extremely generous Family Bonding Leave for eligible employees (16 weeks, paid at 100%)
Supplemental fertility benefits coverage
Retirement savings program including a 4% Company match
Increase paid time off with increased tenure
Latest and greatest hardware (laptop, lab equipment, facilities)
Free daily on-site lunches provided from top eateries
A variety of perks on campus (state of the art gym, restaurant)
Free on-site EV charging (compatible with all EVs, including Tesla)
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses), (2) generous equity options offering, (3) corporate bonus program, on top of (4) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave, etc.).
For this position, we offer a total annual compensation package of $104,322, which includes (1) a base pay range of up to $85,748 per year, (2) eligibility for a semi-annual bonus and (3) equity.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
For more information about how we protect your information, we encourage you to review our Privacy Policy.
BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA,a breakthrough that has already transformed the lives of over half a million patients worldwide.
Our Impact
- Unity Complete™ is the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample.
- Unity Confirm™ enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture™ Technology.
- Our Northstar® liquid biopsy test uniquely combines treatment selection with real-time monitoring, giving oncologists unprecedented precision in cancer care.
Our Growth
From $0 to $400M+ annualized revenue run-rate in just 6 years. In 2025, we completed one of the most successful IPOs for a medical diagnostics company, building on nearly $400M in private funding,including our $130M Series D in 2024 and backed by world-class investors including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest.
Our Recognition
Forbes named us one of America's Best Startup Employers for 2025 and we're Great Place to Work certified, with 100% of our people willing to go the extra mile, even as we've scaled to over 700 employees.
Our Future
Headquartered in Menlo Park with facilities in Union City, CA, and a new lab opening in Austin, TX in 2027, we're continuing to push the boundaries of what's possible in molecular diagnostics. We're just getting started.
Ready to help us change the world, one molecule at a time? Learn more at billiontoone.com
